MedPAC, Industry Debate Renews DME Competitive Bidding Concerns
This article was originally published in The Gray Sheet
Executive Summary
A Medicare Payment Advisory Commission recommendation encouraging Congress to implement competitive bidding for certain types of durable medical equipment has elevated stakeholder concern that all devices falling under the DME fee schedule may eventually be included in a national competitive bidding program
You may also be interested in...
Glucose Monitor Manufacturers Wary As DME Competitive Bidding Looms
Blood glucose monitors and test strips are product areas that may fall under a competitive bidding model in upcoming Medicare reform legislation, according to device stakeholders
Glucose Monitor Manufacturers Wary As DME Competitive Bidding Looms
Blood glucose monitors and test strips are product areas that may fall under a competitive bidding model in upcoming Medicare reform legislation, according to device stakeholders
MedPAC Endorses Competitive Bidding, Calls For Congressional Oversight
The HHS secretary should be given authority to implement permanent competitive pricing for areas with existing DME demonstration projects that have proved successful, pending congressional review and approval, according to MedPAC